Cargando…
Use of B-Cell–Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
PURPOSE OF REVIEW: There is considerable heterogeneity in the use of B-cell depletion in women of childbearing age, likely driven at least in part by the discrepancy between the product labels and what is known about the physiology of IgG1, including breastmilk and placental transfer. RECENT FINDING...
Autores principales: | Galati, Alexandra, McElrath, Thomas, Bove, Riley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208398/ https://www.ncbi.nlm.nih.gov/pubmed/35733945 http://dx.doi.org/10.1212/CPJ.0000000000001147 |
Ejemplares similares
-
The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder
por: Cho, Eun Bin, et al.
Publicado: (2023) -
Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Chen, Hai, et al.
Publicado: (2016) -
Monoclonal Antibody Therapies for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kim, Woojun, et al.
Publicado: (2020) -
Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
por: Hyun, Jae-Won, et al.
Publicado: (2020) -
Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Arslan, Burak, et al.
Publicado: (2021)